跳至主要内容
临床试验/NCT07599618
NCT07599618尚未招募不适用

Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners

University of Rochester1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2026年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1

研究概览

简要总结

The purpose of this study is to determine the feasibility for a patient centered decision-making support tool for older adults with metastatic breast cancer and their care partners.

详细描述

The primary objective (Aim 1) of this study will be to evaluate feasibility of utilizing the patient-centered decision-making (PCDM) tool for older adults with metastatic breast cancer (mBC). The PCDM tool has been developed by the investigators in collaboration with Manta Cares, Inc. During the development process, we have integrated Geriatric Assessment (GA), completed fully by patients, into the PCDM tool, along with potential supportive care strategies (e.g., recommendations) that could be considered by patients and their care partners if areas of impairment are noted on the GA embedded into the PDCM tool. Feasibility of the adapted PCDM tool will be assessed both quantitatively and qualitatively, and through mixed methods (integrating quantitative and qualitative data) to provide a deeper understanding of aspects of implementation across settings.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient Inclusion Criteria:
  • A diagnosis of metastatic breast cancer
  • Age 65 or older
  • Currently receiving systemic treatment for metastatic breast cancer or considering a plan to initiate systemic treatment for metastatic breast cancer
  • Able to speak and read English (because the Manta Cares platform is presently only offered in English only)
  • Able to provide informed consent
  • Care Partner Inclusion Criteria:
  • Age 18 or older
  • Able to speak and read English (because the Manta Cares platform is presently only offered in English only)
  • Able to provide informed consent
  • Verbal permission from patient to enroll their designated care partner

排除标准

  • Patient Exclusion Criteria:
  • Early-stage breast cancer
  • Diagnosis of any other cancer besides metastatic breast cancer
  • Care Partner Exclusion Criteria:
  • 1. Verbal permission from patient to enroll care partner not received.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Allison Magnuson

Principal Investigator

University of Rochester

研究点 (1)

Loading locations...

相似试验